This annual event serves as a platform for introducing groundbreaking therapies, innovative treatment approaches, and the latest technological advancements in the field of IBD.

Refractory Inflammatory Bowel Disease (IBD) continues to present one of the most challenging dilemmas in gastroenterology. Patients with refractory IBD — those who do not respond to conventional treatments — deserve personalized, innovative therapeutic approaches that go beyond the standard care protocols.

Leading experts will dive deep into the latest breakthroughs in managing refractory IBD at this year’s Advances in Inflammatory Bowel Diseases (AIBD) conference, set for December 9-11 at the Walt Disney World Dolphin Hotel in Orlando. This comprehensive event will provide healthcare professionals with the tools, knowledge, and confidence to better navigate the complexities of these difficult cases.

AIBD is dedicated to redefining standards in care, focusing on personalized therapies, biologics and novel treatment combinations for patients with IBD. This annual event serves as a platform for introducing groundbreaking therapies, innovative treatment approaches, and the latest technological advancements in the field of IBD. With real-world data and expert insights at the forefront, the conference aims to empower healthcare professionals to better manage IBD, particularly for patients who do not respond to traditional treatments.

AIBD has curated an exceptional range of sessions to address the most pressing challenges in IBD care. Here are some of the key sessions attendees should not miss:

• Medically Refractory IBD, presented by Bruce Sands, MD, MS, FACG; and
• Surgery Track, moderated by Anthony de Buck van Overstraeten, MD, MSc, and Paulo Kotze, MD, MSc, PhD.

Topics that will be addressed in the Surgery Track include:

• Perianal Sepsis in CD: Step-by-Step Approach;
• Abdominal Abscess Secondary to CD: Drain or Resect;
• Defining the Moment for Urgent Colectomy in UC: Multidisciplinary Thinking;
• Perianal Complex Fistulas in CD: Modern Management;
• Early Ileocolic Resection: Really? Which Anastomosis?; and
• Stricturing Disease Throughout the Bowel: How to Manage?

These sessions will help clinicians sharpen their skills in managing IBD by offering the latest evidence-based strategies for improving patient outcomes.

As the landscape of IBD treatment continues to evolve, this year’s conference will offer invaluable knowledge and tools to stay ahead of the curve. Whether you are a gastroenterologist, surgeon, or healthcare provider involved in IBD care, AIBD will leave you better equipped to tackle IBD with greater confidence and precision.

Gastroenterologists, nurses, physicians, surgeons, and other healthcare professionals in the IBD world should join the more than 2,000 expected to attend AIBD, which will feature 100-plus presentations led by 75 expert faculty presenters and 150 research abstracts. 

AIBD offers an invaluable opportunity to explore the latest innovations and best practices in the field. Register for this must-attend event by visiting the AIBD website.

Whether you’re seeking new strategies to manage refractory cases or looking to deepen your understanding of surgical interventions, this conference promises to provide the tools and knowledge needed to improve patient outcomes and elevate your practice. We hope to see you there as we explore the future of IBD care together.

Dr. Stephen Hanauer is the Clifford Joseph Barborka Professor of Medicine and Medical Director of the Digestive Health Center at Northwestern University’s Feinberg School of Medicine. He is a Fellow and past President of the American College of Gastroenterology (ACG) and the former Chair of the American Gastroenterological Association’s Inflammation, Immunology, and IBD Section.